These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
630 related articles for article (PubMed ID: 32991264)
1. Vaccines to Emerging Viruses: Nipah and Hendra. Amaya M; Broder CC Annu Rev Virol; 2020 Sep; 7(1):447-473. PubMed ID: 32991264 [TBL] [Abstract][Full Text] [Related]
5. Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice. Li Y; Li R; Wang M; Liu Y; Yin Y; Zai X; Song X; Chen Y; Xu J; Chen W Viruses; 2020 Apr; 12(4):. PubMed ID: 32340278 [TBL] [Abstract][Full Text] [Related]
6. Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein. Dong J; Cross RW; Doyle MP; Kose N; Mousa JJ; Annand EJ; Borisevich V; Agans KN; Sutton R; Nargi R; Majedi M; Fenton KA; Reichard W; Bombardi RG; Geisbert TW; Crowe JE Cell; 2020 Dec; 183(6):1536-1550.e17. PubMed ID: 33306954 [TBL] [Abstract][Full Text] [Related]
7. Enzyme-Linked Immunosorbent Assay Using Henipavirus-Receptor EphrinB2 and Monoclonal Antibodies for Detecting Nipah and Hendra Viruses. Zhu W; Smith G; Pickering B; Banadyga L; Yang M Viruses; 2024 May; 16(5):. PubMed ID: 38793674 [TBL] [Abstract][Full Text] [Related]
8. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection. Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218 [TBL] [Abstract][Full Text] [Related]
9. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge. Pallister J; Middleton D; Wang LF; Klein R; Haining J; Robinson R; Yamada M; White J; Payne J; Feng YR; Chan YP; Broder CC Vaccine; 2011 Aug; 29(34):5623-30. PubMed ID: 21689706 [TBL] [Abstract][Full Text] [Related]
11. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins. Dang HV; Cross RW; Borisevich V; Bornholdt ZA; West BR; Chan YP; Mire CE; Da Silva SC; Dimitrov AS; Yan L; Amaya M; Navaratnarajah CK; Zeitlin L; Geisbert TW; Broder CC; Veesler D Nat Struct Mol Biol; 2021 May; 28(5):426-434. PubMed ID: 33927387 [TBL] [Abstract][Full Text] [Related]
12. Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs. Fischer K; Diederich S; Smith G; Reiche S; Pinho Dos Reis V; Stroh E; Groschup MH; Weingartl HM; Balkema-Buschmann A PLoS One; 2018; 13(4):e0194385. PubMed ID: 29708971 [TBL] [Abstract][Full Text] [Related]
13. Henipavirus Immune Evasion and Pathogenesis Mechanisms: Lessons Learnt from Natural Infection and Animal Models. Lawrence P; Escudero-Pérez B Viruses; 2022 Apr; 14(5):. PubMed ID: 35632678 [TBL] [Abstract][Full Text] [Related]
15. Passive immunization and active vaccination against Hendra and Nipah viruses. Broder CC Dev Biol (Basel); 2013; 135():125-38. PubMed ID: 23689890 [TBL] [Abstract][Full Text] [Related]
16. The distribution of henipaviruses in Southeast Asia and Australasia: is Wallace's line a barrier to Nipah virus? Breed AC; Meers J; Sendow I; Bossart KN; Barr JA; Smith I; Wacharapluesadee S; Wang L; Field HE PLoS One; 2013; 8(4):e61316. PubMed ID: 23637812 [TBL] [Abstract][Full Text] [Related]